Rodrigo Doyle Portugal

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Hospital Universitário Clementino Fraga/CCS

Unidade:

Hospital Universitário Clementino Fraga/CCS

Departamento:

Divisão Médica DMD/HU

ORCID:

não disponível no Lattes


Formação:
  • Universidade Federal do Rio de Janeiro

    Clínica Médica | Doutorado | 2007 - 2012
  • Universidade Federal do Rio de Janeiro

    Clínica Médica | Mestrado | 1996 - 1998
  • Universidade Federal do Rio de Janeiro

    | Especialização - Residência medica | 1991 - 1994
  • Universidade Federal do Rio de Janeiro

    Faculdade de Medicina | Graduação | 1985 - 1990
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(76.60% artigos com DOI)

Titulo DOI Ano
Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine 10.1016/j.htct.2023.07.007 2023
AVALIAÇÃO DE TOXICIDADE DO REGIME FLAG PARA LEUCEMIAS AGUDAS 10.1016/j.htct.2023.09.498 2023
NEOPLASMA BLÁSTICO DE CÉLULAS DENDRÍTICAS PLASMOCITOIDES: UMA DOENÇA RARA E DE APRESENTAÇÃO HETEROGÊNEA 10.1016/j.htct.2023.09.471 2023
FLAG (FLUDARABINA, CITARABINA, G-CSF) NO TRATAMENTO DE LEUCEMIAS AGUDAS: EFICÁCIA E TOXICIDADE 10.1016/j.htct.2022.09.253 2022
LINFOMA ANAPLÁSICO DE GRANDES CÉLULAS ALK+ ASSOCIADO A IMPLANTE DE PRÓTESE MAMÁRIA? 10.1016/j.htct.2022.09.160 2022
MDS COM FIBROSE (MDS-F) EVOLUINDO COM LMA RELACIONADA À MIELODISPLASIA (MUTAÇÃO EM ZRSR-2) ANALISADO À LUZ DA NOVA CLASSIFICAÇÃO DA WHO 5ªEDIÇÃO - 2022 10.1016/j.htct.2022.09.348 2022
SÍNDROME DE POEMS COM PADRÃO BICLONAL IGG/KAPPA E IGA/KAPPA 10.1016/j.htct.2022.09.447 2022
CITARABINA 3G/M2 NA INTENSIFICAÇÃO DE ADULTOS COM LEUCEMIA MIELOIDE AGUDA 10.1016/j.htct.2021.10.258 2021
MIDOSTAURIN ADDED TO CYTOSINE ARABINOSIDE PLUS IDARUBICIN (-7+3-) IN NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA 10.1016/j.htct.2021.10.284 2021
SÍNDROME DE SWEET EM LEUCEMIA MIELOIDE AGUDA COM MORFOLOGIA -CUP- LIKE-E MUTAÇÃO FLT3 10.1016/j.htct.2021.10.304 2021
CEREBELLAR DIFFUSE LARGE B CELL LYMPHOMA IN IMMUNOCOMPETENT FEMALE PATIENT 10.1016/j.htct.2021.10.115 2021
TYROSINE KINASE INHIBITORS PLUS HYPER-CVAD FOR THE FRONTLINE TREATMENT OF PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA 10.1016/j.htct.2020.10.316 2020
Current treatment preferences in acute myeloid leukemia: a survey in Brazil 10.1016/j.htct.2019.07.005 2019
Effect of circadian variation on neutrophil mobilization to the peripheral blood in benign constitutional neutropenia 10.1016/j.exphem.2018.10.007 2019
Daunorubicin 90 mg/m 2 in Acute Myeloid Leukemia Induction: Increased Toxicity in Young Patients 10.1016/j.clml.2017.06.018 2017
Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review 10.1080/17474086.2017.1280389 2017
Invasive fungal diseases in patients with acute lymphoid leukemia 10.3109/10428194.2016.1154957 2016
Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing 10.1016/j.bjid.2016.04.007 2016
Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases 10.1111/trf.12993 2015
Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy 10.1186/s13000-015-0365-2 2015
Risk Factors for Invasive Fusariosis in Patients With Acute Myeloid Leukemia and in Hematopoietic Cell Transplant Recipients 10.1093/cid/ciu947 2015
Feasibility and Outcome of the Hyper-CVAD Regimen in Patients With Adult Acute Lymphoblastic Leukemia 10.1016/j.clml.2014.03.004 2014
Risk factors for unsuccessful peripheral blood stem cell harvesting using granulocyte-colony stimulating factor mobilization in patients with multiple myeloma 10.1016/j.transci.2012.06.013 2012
Factors prompting early central venous catheter removal from cancer patients with candidaemia 10.3109/00365548.2010.524657 2011
Weber-Fechner Law and the Optimality of the Logarithmic Scale 10.1007/s11023-010-9221-z 2011
Characterization and analysis of the outcome of adults with acute myeloid leukemia treated in a Brazilian University hospital over three decades 10.1590/S0100-879X2011000700008 2011
Hematologic neoplasias and acromegaly 10.1007/s11102-009-0176-0 2009
Factors associated with hospital readmission in sickle cell disease 10.1186/1471-2326-9-2 2009
A simple score to predict early death in adult cancer patients with bloodstream infections 10.1016/j.jinf.2009.08.009 2009
Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil Curve 10.1200/JCO.2008.21.0856 2009
A computational model for telomere-dependent cell-replicative aging 10.1016/j.biosystems.2007.10.003 2008
Cutaneous granulocytic sarcoma in myelodysplastic syndrome 10.1111/j.1600-0560.2007.00916.x 2008
Acute clinical events in patients with sickle cell disease: epidemiology and treatment 10.1590/S1516-84842008000200005 2008
Set theory and the nosology of hematological malignancies: Lymphomas are characterized by lymphoid differentiation, while leukemia definitions have no common property 10.1016/j.mehy.2006.11.039 2007
Obesity and dose individualization in cancer chemotherapy: The role of body surface area and body mass index 10.1016/j.mehy.2005.04.023 2005
Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation 10.1038/sj.bmt.1704309 2004
Expression of Epstein-Barr virus in patients with Hodgkin 's 2004
Evaluation of pain scale to predict hospital admission in patients with sickle cell disease. 2003
Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study. 2002
Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease 2002
The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. 2001
Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. 2000
Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients. 1998
Resistance to activated protein C in thrombophilic patients in Rio de Janeiro. 1998
Risk factors for typhlitis: A case-control study 1997
Clinical factors predictive of bone marrow involvement in Hodgkin's disease 1997
Strongyloidiasis in patients with hematologic malignancies. 1995
Eventos:

(3.12% eventos com DOI)

Titulo DOI Ano
'MIDOSTAURIN ADDED TO CYTOSINE ARABINOSIDE PLUS IDARUBICIN (?7+3?) IN NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA.' 2021
'CITARABINA 3G/M2 NA INTENSIFICAÇÃO DE ADULTOS COM LEUCEMIA MIELOIDE AGUDA.' 2021
'CEREBELLAR DIFFUSE LARGE B CELL LYMPHOMA IN IMMUNOCOMPETENT FEMALE PATIENT.' d 2021
MonTemp: Dispositivo de Monitorização Contínua de Temperatura 2018
Effect of Circadian Variation on Neutrophil Mobilization to Peripheral Blood in Benign constitucional Neutropenia 2016
Validation of Bone Marrow Aspirates in Adult Patients With Acute Myeloid Leukemia at Day 14 of Induction Therapy 2011
Feasibility of the Hyper-CVAD in adolescents and adults patients with acute lymphoblastic leukemia. 2010
Improvement of survival of adults with acute myeloid leukemia in a brazilian university center from 1980s to the early 21st century 2010
A clinical model for predicting severe medical complications in cancer patients with bloddstream infections. 2008
Influence of Central Venous Catheter Management on Outcome in Cancer Patients with Candidemia who Survived more than 72 Hours after the First Positive Blood Culture 10.1016/S1201-9712(08)60069-7 2008
An index to predict invasive mould infection in high-risk neutropenic patients based on the area over the neutrophil curve 2007
An Index to predict invasive mould infections in acute myeloid leukemia patiebts based on the area over the neutrophil curve 2007
Características e evolução de pacientes com leucemia mielóide aguda tratados em uma instituição nas últimas três décadas 2007
Should hypercvad/ Methotrexate-Cytarabine be considered a standard treatment in acute Lymphoblastic Leukemia? Brazilian experience. 2006
Anemia perniciosa associada a tireoidite de Hashimoto:relato de caso 2005
Características demográficas e clínicas dos pacientes portadores de doença falciforme internados em um hospital universitário 2005
Uso de opióides em pacientes com doença falciforme:resultados preliminares de um estudo observacional 2005
Elevada taxa de remissão Completa em pacientes com leucemia linfóide aguda (LLA) utilizando-se o protocolo Hyper- CVAD 2003
Morbidade em anemia falciforme: estudo de pacientes acompanhados em um hospital universitário 2003
Significado da febre em pacientes com doença falciforme: uma avaliação prospectiva 2002
Importância clínica da utilização de escala de dor em pacientes com doença falciforme 2002
Autologous peripheral blood progenitor cells transplantation for the treatment of multiple myeloma 2001
Ensino de Hematologia: comparação entre um curso baseado em aulas e um curso baseado em problemas. 1999
Fatores prognósticos na LLA da infância: análise prospectiva de 55 casos tratados com protocolos baseados no BFM 90 e BFM 95 1999
ABVP chemotherapy as primary therapy for Hodgkin´s disease 1999
Fatores associados com a duração da febre em pacientes submetidos a transplante autólogo de células tronco progenitoras 1999
Thiabendazole versus placebo in the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a double-blind randomized study 1998
Prevalence and outcome of tuberculosis in patients with Hodgkin's diasease 1998
Clinical efficacy of thiabendazole in the treatment of immunosuppressed patients with strongyloidiasis 1998
Quimioterapia em altas doses seguido de transplante autólogo no tratamento do mieloma múltiplo 1998
Association of adult T cell lymphoma (ATL) and recurrent strongyloidiasis 1994
Strongyloidiasis in patients with hematological malignancies 1994
Publicações:
Minha Rede: